Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficient patients with mutated GH-releasing hormone receptor

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 7, 2001, Pages 3279-3283

  Gondo, Rogerio G ^a   Aguiar Oliveira, Manuel H ^b   Hayashida, César Y ^a   Toledot, Sergio P A ^a   Abelin, Neusa ^a   Levine, Michael A ^c   Bowers, Cyril Y ^d   Souza, Anita H O ^b   Pereira, Rossana M C ^b   Santos, Norma L ^b   Salvatori, Roberto ^c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR RECEPTOR; HYDROCORTISONE; HYPOPHYSIS HORMONE; PRALMORELIN; PROLACTIN; THYROTROPIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONAL REGULATION; HORMONE BLOOD LEVEL; HUMAN; HYPOPHYSIS; HYPOPHYSIS CELL; MALE; PRIORITY JOURNAL; SOMATIC CELL; TREATMENT OUTCOME;

ADRENOCORTICOTROPIC HORMONE; HORMONES; HUMAN GROWTH HORMONE; HYDROCORTISONE; MUTATION; OLIGOPEPTIDES; PITUITARY GLAND; PROLACTIN; RECEPTORS, NEUROPEPTIDE; RECEPTORS, PITUITARY HORMONE-REGULATING HORMONE; THYROTROPIN;

EID: 17844389840     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.7.3279     Document Type: Article

References (41)

1. Growth hormone-releasing peptide (GHRP)
2. Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers
3. Growth hormone-releasing activity of hexarelin in humans. A dose-response study
4. Tyr-Ala-hexarelin, a synthetic octapeptide, possesses the same endocrine activities of hexarelin and GHRP-2 in humans
5. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels
6. 1994 Effects of acute and repeated intravenous administration of L-692,585, a novel non-peptidyl growth hormone secretagogue, on plasma growth hormone, IGF-1, ACTH, cortisol, prolactin, insulin, and thyroxine levels in beagles
7. Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects
8. Growth hormone-releasing peptide-6 stimulates sleep, growth hormone, ACTH and cortisol release in normal man
9. Cardiac effects of hexarelin in hypopituitary adults
10. Growth hormone-releasing peptides and the cardiovascular system
11. Identification and characterization of a new growth hormone-releasing peptide receptor in the heart
12. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland
13. Ghrelin is a growth-hormone-releasing acylated peptide from stomach
14. Central actions of peptide and non-peptide growth hormone secretagogues in the rat
15. GH-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep
16. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: Evidence that GHRP-6 main action is exerted at the hypothalamic level
17. Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene
18. Familial growth hormone deficiency with mutated GHRH receptor gene: Clinical and hormonal findings in homozygous and heterozygous individuals from Itabaianinha
19. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life
20. Serum leptin and body composition in children with familial GH deficiency (GHD) due to a mutation in the growth hormone-releasing hormone (GHRH) receptor
21. Use and interpretation of anthropometric indicators of nutritional status
22. Standardized percentile curves of body-mass index for children and adolescents
23. Race- and sex-specific reference data for triceps and subscapular skinfolds and weight/stature
24. Presence of specific receptors for hexarelin, a GH releasing hexapeptide, in human brain and pituitary gland
25. Growth hormone-releasing peptide receptor in human brain and pituitary gland
26. Specific receptors for synthetic GH secretagogues in the human brain and pituitary gland
27. Neuroendocrine control of growth hormone secretion
28. Molecular and cell biology of the growth hormone-releasing hormone receptor
29. Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse
30. Extensive phenotypic analysis of a family with growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene
31. Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: Dwarfism of Sindh
32. A novel growth hormone releasing hormone (GHRH) receptor mutation as a cause for isolated GH deficiency in a Japanese boy with severe short stature
33. Three new mutations in the gene for the growth hormone (GH)-releasing hormone receptor in familial isolated GH deficiency type IB
34. Molecular basis of the little mouse phenotype and implications for cell type-specific growth
35. GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function
36. The mutant growth hormone-releasing hormone (GHRH) receptor of the little mouse does not bind GHRH
37. Pituitary hypoplasia in patients with a mutation in the growth hormone-releasing hormone receptor gene
38. Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency
39. Growth hormone-releasing peptides
40. Effects of eight months treatment with graded doses of a growth hormone (GH)-releasing peptide in GH-deficient children
41. MK-677, an orally active growth hormone secretagogue, reverses diet-induced catabolism